Charles DeBattista, MD

  • 8Articles
  • 43.2KReads
  • 1999–2025Active
  • 60Collaborators
  • 281Citations

About

Charles DeBattista, MD, is affiliated with Stanford University School of Medicine in Stanford, California. With publications spanning from 1999 to 2025, DeBattista has contributed extensively to research on major depressive disorder, neurology, sexual dysfunction, and violence and aggression. His work includes clinical trials on antidepressant treatments, pharmacogenomics, and adjunctive therapies for depression-related symptoms. DeBattista has frequently collaborated with authors such as Michael E. Thase and Maurizio Fava, publishing in Psychiatrist.com journals.

Publications

JCP
Effect of Aripiprazole or rTMS Augmentation Versus Switching to Venlafaxine on Quality of Life
Original Research

Effect of Aripiprazole or rTMS Augmentation Versus Switching to Venlafaxine on Quality of Life

August 11, 2025

Augmentation with aripiprazole, but not rTMS, improved quality of life significantly versus venlafaxine XR/duloxetine switch in patients with treatment-resistant depression.
, , , et al
JCP
Effect of Benzodiazepines on Antidepressant Effects of Ketamine
Original Research

Effect of Benzodiazepines on Antidepressant Effects of Ketamine

November 14, 2022

Findings of studies examining the impact of benzodiazepines on antidepressant effects of ketamine are contradictory. This study assessed whether concomitant oral benzodiazepines differentially affected treatment response to ketamine versus...
, , , et al
JCP
Original Research

Utility of Combinatorial Pharmacogenomics in Depression

October 31, 2019

This study sought to ascertain the extent that pharmacogenetic testing can inform treatment decisions among patients with treatment-resistant depression whose medications are subject to gene-drug interactions—read the article to...
, , , et al
JCP
Original Research

A Placebo-Controlled, Randomized, Double-Blind Study of Adjunctive Bupropion Sustained Release in the Treatment of SSRI-Induced Sexual Dysfunction

July 15, 2005

, , , et al
JCP
Original Research

A Multicenter, Placebo-Controlled Study of Modafinil Augmentation in Partial Responders to Selective Serotonin Reuptake Inhibitors With Persistent Fatigue and Sleepiness

January 15, 2005

, ,
JCP
Original Research

Adjunct Modafinil for the Short-Term Treatment of Fatigue and Sleepiness in Patients With Major Depressive Disorder: A Preliminary Double-Blind, Placebo-Controlled Study

September 15, 2003

, , , et al
JCP
Article

Phenomenology and Treatment of Agitation

June 1, 1999

,
JCP
Original Research

The Texas Medication Algorithm Project: Report of the Texas Consensus Conference Panel on Medication Treatment of Major Depressive Disorder

March 31, 1999

, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe